Irati Garmendia
San Sebastian, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial.
Journal: Journal of geriatric oncology
Published: September 03, 2025
Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial.
Journal: Journal of geriatric oncology
Published: September 03, 2025
Machine learning for predicting the diagnosis of tuberculous versus malignant pleural effusion: External validation and accuracy in two different settings.
Journal: PloS one
Published: March 22, 2025
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.
Journal: International journal of molecular sciences
Published: August 29, 2022
Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment.
Journal: Cancer immunology research
Published: July 04, 2022
YES1 Is a Druggable Oncogenic Target in SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 02, 2022
YES1: A Novel Therapeutic Target and Biomarker in Cancer.
Journal: Molecular cancer therapeutics
Published: December 03, 2021
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2021
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
Journal: Cancer immunology, immunotherapy : CII
Published: December 28, 2019
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.
Journal: Journal of clinical medicine
Published: July 23, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
Journal: American journal of respiratory and critical care medicine
Published: June 06, 2019
Last Updated: 09/26/2026